Ametamey S - Search Results

1

In vivo properties of N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamide 18F- and 123I-labelled reversible inhibitors of monoamine oxidase B.

Bläuenstein P, Rémy N, Buck A, Ametamey S, Häberli M, Schubiger PA. Bläuenstein P, et al. Among authors: ametamey s. Nucl Med Biol. 1998 Jan;25(1):47-52. doi: 10.1016/s0969-8051(97)00143-1. Nucl Med Biol. 1998. PMID: 9466361

2

PET imaging of dopamine transporters in the human brain using [(11)C]-beta-CPPIT, a cocaine derivative lacking the 2 beta-ester function.

Schönbächler RD, Gucker PM, Arigoni M, Kneifel S, Vollenweider FX, Buck A, Burger C, Berthold T, Brühlmeier M, Schubiger PA, Ametamey SM. Schönbächler RD, et al. Among authors: ametamey sm. Nucl Med Biol. 2002 Jan;29(1):19-27. doi: 10.1016/s0969-8051(01)00271-2. Nucl Med Biol. 2002. PMID: 11786272 Clinical Trial.

3

Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.

Ametamey SM, Beer HF, Guenther I, Antonini A, Leenders KL, Waldmeier PC, Schubiger PA. Ametamey SM, et al. Nucl Med Biol. 1996 Apr;23(3):229-34. doi: 10.1016/0969-8051(95)02051-9. Nucl Med Biol. 1996. PMID: 8782230

4

PET studies of 18F-memantine in healthy volunteers.

Ametamey SM, Bruehlmeier M, Kneifel S, Kokic M, Honer M, Arigoni M, Buck A, Burger C, Samnick S, Quack G, Schubiger PA. Ametamey SM, et al. Nucl Med Biol. 2002 Feb;29(2):227-31. doi: 10.1016/s0969-8051(01)00293-1. Nucl Med Biol. 2002. PMID: 11823128 Clinical Trial.

5

Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex.

Samnick S, Ametamey S, Leenders KL, Vontobel P, Quack G, Parsons CG, Neu H, Schubiger PA. Samnick S, et al. Among authors: ametamey s. Nucl Med Biol. 1998 May;25(4):323-30. doi: 10.1016/s0969-8051(98)00003-1. Nucl Med Biol. 1998. PMID: 9639292

6

Synthesis and in vitro and in vivo evaluation of [11C]methyl-BIII277CL for imaging the PCP-binding site of the NMDA receptor by pet.

Kokic M, Honer M, Kessler LJ, Grauert M, Schubiger PA, Ametamey SM. Kokic M, et al. J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):123-39. doi: 10.1081/rrs-120014591. J Recept Signal Transduct Res. 2002. PMID: 12503611

7

Measurement of the extracellular space in brain tumors using 76Br-bromide and PET.

Bruehlmeier M, Roelcke U, Bläuenstein P, Missimer J, Schubiger PA, Locher JT, Pellikka R, Ametamey SM. Bruehlmeier M, et al. J Nucl Med. 2003 Aug;44(8):1210-8. J Nucl Med. 2003. PMID: 12902409 Free article. Clinical Trial.

8

NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours.

Wyss MT, Honer M, Schubiger PA, Ametamey SM. Wyss MT, et al. Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):311-8. doi: 10.1007/s00259-005-1951-4. Epub 2005 Oct 29. Eur J Nucl Med Mol Imaging. 2006. PMID: 16258762 Free article.

9

Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.

Honer M, Stoffel A, Kessler LJ, Schubiger PA, Ametamey SM. Honer M, et al. Nucl Med Biol. 2007 Nov;34(8):973-80. doi: 10.1016/j.nucmedbio.2007.07.017. Epub 2007 Sep 19. Nucl Med Biol. 2007. PMID: 17998101

10

Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.

Lucatelli C, Honer M, Salazar JF, Ross TL, Schubiger PA, Ametamey SM. Lucatelli C, et al. Nucl Med Biol. 2009 Aug;36(6):613-22. doi: 10.1016/j.nucmedbio.2009.03.005. Nucl Med Biol. 2009. PMID: 19647167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters